Skip to main content
. Author manuscript; available in PMC: 2019 May 29.
Published in final edited form as: Cancer Res. 2018 Sep 12;78(23):6680–6690. doi: 10.1158/0008-5472.CAN-17-3878

Figure 1. IMO-8503 impairs human TLR8 activation promoted by synthetic miR-21.

Figure 1.

QUANTI-Blue assay performed on Human HEKBlue-TLR8 293 cells treated for 24h with Dotap formulation of miR-21 in the presence of the indicated concentrations of IMO-8503. Incubation with only miR-21 was used as positive control. Experiment was performed in triplicate. Results are presented as average ± S.D. Statistical analysis was performed by one-way ANOVA test.